(Medical Xpress) -- A vaccine delivered to the skin using a microneedle patch gives better protection against the H1N1 influenza virus than a vaccine delivered through subcutaneous or intramuscular injection, researchers ...
Jul 12, 2011
1
0
With the U.S. facing vaccination delays because of worker shortages and distribution problems, federal health officials now say it's OK to push back the second dose of the two-part vaccine by as much as six weeks.
Jan 28, 2021
0
11
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.
Jan 22, 2018
0
250
In a scientific discovery that has significant implications for preventing HIV infections, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have identified a protein that could improve the body's ...
Jun 4, 2015
0
28
A team led by Monash University and the University of Queensland has developed a new approach to harnessing the body's immune system to fight disease that could pave the way for a new class of cancer vaccine.
Jun 2, 2016
0
16
Vaccines work by giving our immune system a 'heads up' about a known threat. They are traditionally given before we encounter a pathogen (such as the influenza virus), allowing our bodies to mount a better immune response ...
Oct 18, 2023
0
1
Researchers at Queen Mary, University of London have discovered how a key molecule controls the body's inflammatory responses. The molecule, known as p110delta, fine-tunes inflammation to avoid excessive reactions that can ...
Sep 30, 2012
0
0
A multi-institutional collaborative has developed a novel mRNA derivative and demonstrated its high cellular-immunity-inducing anti-cancer activities in a mouse model. This novel mRNA, with a comb-like structure and double-stranded ...
Jul 13, 2023
0
11
A vaccine created to prevent the recurrence of the deadly skin cancer melanoma is about twice as effective when patients also receive two components that boost the number and effectiveness of immune system cells called dendritic ...
Nov 16, 2020
0
47
Eight of 16 patients participating in a study of an experimental immune system therapy directed against the most aggressive malignant brain tumors – glioblastoma multiforme – survived longer than five years after diagnosis, ...
Nov 24, 2013
0
0
